Inventor · disambiguated record
Ellen K. Wasan
Also filed as: WASAN ELLEN · WASAN ELLEN K
5 granted patents·5 pending applications·148 citations·filing 1997–2019
75Inventor score
Files withUNIV SASKATCHEWAN3UNIV BRITISH COLUMBIA2WASAN KISHOR M2BC CANCER AGENCY1INEX PHARMACEUTICALS CORP1
Top patents by PatentIndex Score
10 records- 0191US5965542AUse of temperature to control the size of cationic liposome/plasmid DNA complexesINEX PHARMACEUTICALS CORP·Filed 1997·Granted Oct 12, 1999·146 cites·17 claims
- 0277US10543202B2Topical nifedipine formulations and uses thereofUNIV SASKATCHEWAN·Filed 2018·Granted Jan 28, 2020·1 cites·20 claims
- 0363US8592382B2Formulations for the oral administration of therapeutic agents and related methodsWASAN KISHOR M·Filed 2008·Granted Nov 26, 2013·1 cites·17 claims
- 0452US8673866B2Stabilized formulation for oral administration of therapeutic agents and related methodsWASAN KISHOR M·Filed 2012·Granted Mar 18, 2014·0 cites·17 claims
- 0551US10835489B2Modified release formulations of mycophenolate mofetilUNIV SASKATCHEWAN·Filed 2019·Granted Nov 17, 2020·0 cites·28 claims
- 0648US2021267890A1Mucoadhesive lipidic delivery systemUNIV SASKATCHEWAN·Filed 2019·Application pending·0 cites
- 0746US2008026049A1Liposomal compositions for parenteral delivery of agentsWASAN ELLEN·Filed 2007·Application pending·0 cites
- 0845US2014228309A1Stabilized formulation for oral administration of therapeutic agents and related methodsUNIV BRITISH COLUMBIA·Filed 2014·Application pending·0 cites
- 0944US2014228308A1Formulations for the oral administration of therapeutic agents and related methodsUNIV BRITISH COLUMBIA·Filed 2013·Application pending·0 cites
- 1044US2009028931A1Liposomal compositions for parenteral delivery of agentsBC CANCER AGENCY·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ellen K. Wasan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →